tiprankstipranks
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen price target raised to $36 from $32 at H.C. Wainwright
The FlySurrozen price target raised to $36 from $32 at H.C. Wainwright
18d ago
SRZN
Surrozen files $200M mixed securities shelf
PremiumThe Fly
Surrozen files $200M mixed securities shelf
18d ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
25d ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
2M ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany Announcements
Surrozen announces routine board resignation with no disputes
2M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
PremiumRatingsSurrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
5M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
Premium
The Fly
Surrozen initiated with an Outperform at LifeSci Capital
5M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
Premium
Company Announcements
Surrozen, Inc. Reports Significant Q3 2025 Loss
5M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
PremiumRatings
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
5M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
PremiumCompany Announcements
Surrozen Appoints Andrew Maleki as New CFO
5M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
PremiumThe Fly
Surrozen names Andrew Maleki as CFO
5M ago
SRZN
Surrozen’s Collaboration Agreement with TCGFB Terminated
PremiumCompany Announcements
Surrozen’s Collaboration Agreement with TCGFB Terminated
6M ago
8K
SRZN
Surrozen Signs $50M Sales Agreement with TD Securities
PremiumCompany AnnouncementsSurrozen Signs $50M Sales Agreement with TD Securities
7M ago
8K
SRZN
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
Premium
Ratings
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
8M ago
SRZN
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
Premium
Company Announcements
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
8M ago
SRZN
Surrozen files $150M mixed securities shelf
PremiumThe Fly
Surrozen files $150M mixed securities shelf
11M ago
SRZN
Surrozen Holds Successful 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Surrozen Holds Successful 2025 Annual Stockholders Meeting
11M ago
8K
SRZN
Surrozen granted patent from USPTO directed to antibody-based molecules
PremiumThe Fly
Surrozen granted patent from USPTO directed to antibody-based molecules
11M ago
SRZN
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
PremiumRatings
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
11M ago
SRZN
Surrozen, Inc. Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsSurrozen, Inc. Reports Q1 2025 Financial Results
11M ago
SRZN
Surrozen files to sell 5.21M shares of common stock for holders
Premium
The Fly
Surrozen files to sell 5.21M shares of common stock for holders
12M ago
SRZN
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
Premium
Ratings
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
1y ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >